IceCure Final Breast Cancer Cryoablation Trial 100% Patient, Physician Satisfaction, 96.3% Recurrence Free

 

• Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fine wins Scientific Impact Award as voted by breast surgeons 
• President-Elect of the ASBrS, Dr. Michael Berry, presents data and states "cryoablation is ready for prime time" 
• Company seeks indication for treating women with early stage T1 invasive breast cancer with adjuvant hormone therapy 
• Available reimbursement code for facility expense expected to enhance usage upon receiving marketing authorization
• Minimally-invasive ProSense® cryoablation offers highly favorable healthcare economics 

https://www.biospace.com/article/releases/icecure-medical-reports-final-ice3-breast-cancer-cryoablation-trial-results-of-100-percent-patient-and-physician-satisfaction-and-96-3-percent-recurrence-free-/